Literature DB >> 28700114

Increasing incidence of melanoma after solid organ transplantation: a retrospective epidemiological study.

Kinda Fattouh1, Emilie Ducroux1, Evelyne Decullier2,3, Jean Kanitakis1, Emmanuel Morelon4, Pascale Boissonnat5, Laurent Sebbag5, Denis Jullien1, Sylvie Euvrard1.   

Abstract

The risk of melanoma in organ transplant recipients (OTR) is increased compared with the general population. This retrospective study registered all cases of post-transplant melanoma in kidney, heart, lung, and liver transplant recipients followed in our specialized post-transplant Dermatology Clinic since 1991. The yearly prevalence of melanoma and skin carcinoma between 2000 and 2015 was computed and compared in this population. Based on another cohort of kidney transplant recipients grafted since 2005, adjusted age- and sex-standardized incidence ratio (SIR) was calculated using a renal transplantation registry. In our overall OTR cohort, between 1991 and 2000, five melanomas occurred in 1800 OTRs (0.28%), whereas between 1991 and 2015, 53 melanomas were diagnosed in 49 of 4510 OTR (1.09%), representing a 3.9-fold increase in prevalence after 2000. Remarkably, the prevalence of nonmelanoma skin cancers remained unchanged over this period. Two deaths related to melanoma were recorded with an overall follow-up of 62 months. In our cohort of 1102 renal transplant recipients, the SIR of melanoma was 4.52. Our data suggest that contrasting with nonmelanoma skin cancer, the risk of post-transplant melanoma has considerably increased over the last decade.
© 2017 Steunstichting ESOT.

Entities:  

Keywords:  immunosuppression; incidence; melanoma; organ transplantation; skin cancer

Mesh:

Year:  2017        PMID: 28700114     DOI: 10.1111/tri.13011

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  4 in total

Review 1.  Roles of UVA radiation and DNA damage responses in melanoma pathogenesis.

Authors:  Aiman Q Khan; Jeffrey B Travers; Michael G Kemp
Journal:  Environ Mol Mutagen       Date:  2018-02-21       Impact factor: 3.216

Review 2.  Dermatological Complications After Solid Organ Transplantation.

Authors:  Luigi Naldi; Anna Venturuzzo; Pietro Invernizzi
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 10.817

3.  Combination checkpoint blockade for metastatic cutaneous malignancies in kidney transplant recipients.

Authors:  Megan H Trager; Shana M Coley; Geoffrey Dube; Shaheer Khan; Matthew Ingham; Faramarz H Samie; Larisa J Geskin; Diana McDonnell; Daniel Brouder; Yvonne Saenger; Richard Carvajal
Journal:  J Immunother Cancer       Date:  2020-06       Impact factor: 13.751

4.  Use of Immunomodulating Drugs and Risk of Cutaneous Melanoma: A Nationwide Nested Case-Control Study.

Authors:  Leon Alexander Mclaren Berge; Bettina Kulle Andreassen; Jo Steinson Stenehjem; Trond Heir; Øystein Karlstad; Asta Juzeniene; Reza Ghiasvand; Inger Kristin Larsen; Adele C Green; Marit Bragelien Veierød; Trude Eid Robsahm
Journal:  Clin Epidemiol       Date:  2020-12-18       Impact factor: 4.790

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.